Lung Cancer: Non-Small Cell (NSCLC)

Home > Cancer Types > Carcinoma > Lung Cancer: Non-Small Cell (NSCLC)

Lung Cancer: Non-Small Cell (NSCLC) Treatment Guide

This diagnosis-specific guide explains current evidence on standard treatments, including benefits, risks, side effects and key questions to ask your doctors. It is based on independent research...

New Developments in Complementary Cancer Treatment – Baden Baden, Germany

Why We Are Losing the War on Cancer

Testimony To The House Committee On Government Reform And Oversight

Testimony To The House Committee On Government Reform And OversightBy Ralph W. Moss, Ph.D.February 4, 1998[Reprinted from Patient Access to Alternative Treatments: Beyond the FDA, Hearings Before...

Trophoblasts and Cancer

HCG, A Marker for the Presence of Cancer An article in the orthodox journal, Cancer, has established that a natural hormone called human chorionic gonadotropin, or "hCG," is an accurate marker...

Photodynamic Therapy (PDT)

New Light on an Old ProblemPhotodynamic therapy (PDT) is much more effective for lung cancer than was previously thought, Thomas Jefferson University researchers said last week. The Philadelphia...

Galavit™ – Cancer Fighting Potential?

Galavit™ A Friendly Skeptics View I first came across Galavit® in November 2000, while on a tour of German complementary and alternative (CAM) cancer clinics. There had been an enthusiastic...

Hydrazine Sulfate Trials and Tribulations

Where are your randomized controlled trials? … is the usual response to proponents of alternative cancer therapies. And, indeed, there are few rigorous clinical studies of most unconventional...

Keytruda: Toxic, Expensive and Not So Effective

Best Selling Cancer Drug in 2019 Keytruda® (pembrolizumab) is toxic, expensive, and not as effective as one would wish. But at $7.2 billion, it was the best-selling cancer drug in 2019. At the...

The Great Antioxidant Debate

Safety of Antioxidants In January 2013, James D. Watson, Ph.D., co-discoverer of DNA's double helix, published a paper in which he called into doubt the safety of antioxidants for cancer...

Can Chemotherapy Kill You?

Ten Scientific StudiesHere, we will consider ten scientific studies that show that chemotherapy quickly kills a certain percentage of patients who receive it. In most studies that number is in...

The Case of Xalkori (crizotinib)

Conflicts of InterestAlmost every study of a new cancer drug is riddled with conflicts of interest. Let us focus on one of these drugs, crizotinib (Xalkori®). But we could conduct the same sort...

The Strange Case of Xalkori

A Great Success Story?Let us look at a drug that is considered one of the great success stories of the precision medicine approach, Xalkori (crizotinib). The story of Xalkori illustrates some of...

Green Tea as an Immune Checkpoint Inhibitor

Value in Prevention and Treatment One of the most exciting developments in cancer in the past 30 years has been a treatment strategy known as immune checkpoint blockade. ICB relies on a...

Do “Targeted Therapies” Hit the Mark?

The Cancer Genome Landscape The journal Science published a revealing report on the work of Charles Swanton, MD, showing that “tumors are a mosaic of different cells” (Gerlinger 2012)....

Coffee Cuts the Risk of Cancer

Big Battle Brewing Drinking coffee cut the risk of colorectal cancer recurring in half. In a big study, 953 patients with stage III cancer kept a detailed record of their food and drink intake....

Exporting Cancer, American Style

I saw this scene with my own eyes in Budapest in 1991. The American “invasion” of Hungary. An international committee has established that there are now 17.2 million cancer cases and 8.9 million...

The Neutrophil-to-Lymphocyte Ratio (NLR) and What It Means

How Can You Tell If Your Immune System Is Deficient? One simple way to tell if your immune system is deficient is to learn how to interpret your complete blood count (CBC). If any of the numbers...

Tarceva is Becoming a Standard Therapy for Lung Cancer

But does it work? Some prominent oncologists are urging that the “targeted” drugs bevacizumab (Avastin®) and erlotinib (Tarceva®) be routinely added to standard chemotherapy for non-small cell...

FDA Approves Research of Traditional Chinese Medicine

Kanglaite The US Food and Drug Administration (FDA) has approved a clinical trial of Kanglaite®, a drug derived from an herb used in Traditional Chinese Medicine (TOM). The source of the drug is...

Lung Cancer and Xalkori

Companion Diagnostics In August 2011, the FDA approved Pfizer’s new anticancer pill, crizotinib (Xalkori®). The approval was unusual in several respects. Approval was for a very specific...

Drugs Approved for Lung Cancer

Statistical Improvement?The past 40 years have certainly seen the introduction of numerous anticancer agents for lung cancer. In the past decade and a half, the Food and Drug...

Fate of Endostatin

An Instructive Look It is instructive to look at endostatin, a much-touted angiogenesis inhibitor treatment. The New York Times once ran a front-page story in which prominent scientists virtually...

Do PARP Inhibitors Work?

Poly ADP Ribose Polymerase The acronym PARP stands for “poly ADP ribose polymerase.” For the past few years, a great many hopes have been riding on the alleged effectiveness of this...

Exciting Tests for Cancer – Blood Tests, ENOX2 and ONCOblot

Noninvasive Blood Tests for CancerThis is an exciting time for noninvasive blood tests for cancer. Several biotech companies are vying to become the first to introduce a “liquid biopsy.” This is...

The Human Genome Project Reconsidered

Nobel Laureate James D. Watson PhD The 1990s and early 2000s coincided with the span of the Human Genome Project, of which the Nobel laureate James D. Watson, Ph.D., was the U.S. director. (He...

Companion Diagnostic Tests

An Excellent BusinessCompanion diagnostic testing is an excellent business, since everyone with a particular type of cancer is a candidate for the test, while only a minority who are positive for...

Liquid Biopsies Approved By FDA

Liquid Biopsies Approved By FDA At this writing, the U.S. Food and Drug Administration (FDA) has approved the following liquid biopsy tests in a general way for a broad spectrum of cancers:...

Freight Train accelerated approval of FDA Drugs

FDA’s Accelerated Approvals

Speed Isn’t Everything The Food and Drug Administration (FDA) approves many cancer drugs using a so-called “accelerated approval” process. As they explain at FDA.gov, “Mindful of the fact that it...

NCCN Recommendations for NSCLC

Setting the StandardThe National Comprehensive Cancer Network (nccn.org) is an alliance of 32 U.S. cancer centers. Their experts diagnose and treat all cancers, but with a focus on complex,...

Angiogenesis Inhibitors

Doubts Arise New doubts have been raised about the safety and efficacy of drugs known as angiogenesis inhibitors. These drugs are designed to block the development of new blood vessels within and...

Early Detection and Policy

Von Eschenbach's Challenge In 2006, The Bush Administration announced its intention of cutting a program that provides free breast and cervical cancer screening for low-income, working...

Terminally Ill Patients Are Not Guinea Pigs

New Scientist Article In 2006, the US Court of Appeals for the District of Columbia made a decision of huge consequence. It ruled that terminally ill cancer patients have a constitutional right...

Cancer on the Decline: Playing with Numbers

If you listened to the mainstream media in February 2006, you might have thought that the end of cancer was finally in sight. The cancer death rates were down for the first time in over 70 years....

Are We Making Progress in the War on Cancer?

[This is a version of the speech that I gave in Munich on June 16, 2012, at the 2nd Annual International Conference on Integrative Oncology of the German Society of Oncology (DGO).] First, I want...

Mushrooms Against Cancer

Value in Traditional Medicine Mushrooms are important for cancer patients. If you find yourself in a dangerous situation, vis-a-vis the state of your immune system, you will be urgently looking...